Trader Joe’s and Ajinomoto Foods voluntarily recalled frozen meals nationwide after multiple consumer complaints about glass in the products.

Risankizumab showed high rates of clinical remission and endoscopic response when administered as subcutaneous induction therapy for moderate to severe CD.

Patients with chronic migraine initiating GLP-1 RAs showed decreased health care utilization compared with those taking topiramate.

Response and remission rates to immunosuppressive therapy was similar in Crohn disease (CD) with upper gastrointestinal (GI) involvement or extensive CD (ECD), according to study ...

Eighteen states adopted cost-cutting changes to AIDS Drug Assistance Programs, potentially increasing HIV transmission and drug resistance.

Nutrition and lifestyle interventions, including whole-food plant-based diets, show promise in managing mood disorders and ...

Colorectal cancer incidence and mortality increased among adults younger than 65 years while declining in older populations from 2013 to 2022.

Clinically significant fatigue affects half of individuals with MASLD and is linked to depression, anxiety, and ...

The prevalence of obesity and severe obesity in the United States increased among both adults and children from the 1970s to 2023.

Infliximab and upadacitinib have the highest week 2 rates and postinduction PRO-2 response among individuals with UC who are biologic-naïve with severe endoscopic disease.

Zepbound KwikPen, a 4-dose single-patient delivery device for tirzepatide administration has been made available by Lilly.